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Abstract
Background: The use of proportional weight gain as a discharge criterion for MUAC admissions to programs
treating severe acute malnutrition (SAM) is no longer recommended by WHO. The critical limitation with the
proportional weight gain criterion was that children who are most severely malnourished tended to receive
shorter treatment compared to less severely malnourished children. Studies have shown that using a discharge criterion
of MUAC≥ 125 mm eliminates this problem but concerns remain over the duration of treatment required to reach this
criterion and whether this discharge criterion is safe. This study assessed the safety and practicability of using MUAC ≥
125 mm as a discharge criterion for community based management of SAM in children aged 6 to 59 months.
Methods: A standards-based trial was undertaken in health facilities for the outpatient treatment of SAM in Lilongwe
District, Malawi. 258 children aged 6 to 51 months were enrolled with uncomplicated SAM as defined by a MUAC equal
or less than 115 mm without serious medical complications. Children were discharged from treatment as ‘cured’ when
they achieved a MUAC of 125 mm or greater for two consecutive visits. After discharge, children were followed-up at
home every two weeks for three months.
Results: This study confirms that a MUAC discharge criterion of 125 mm or greater is a safe discharge criterion and is
associated with low levels of relapse to SAM (1.9 %) and mortality (1.3 %) with long durations of treatment seen only
in the most severe SAM cases. The proportion of children experiencing a negative outcome was 3.2 % and significantly
below the 10 % standard (p = 0.0013) established for the study. All children with negative outcomes had
achieved weight-for-height z-score (WHZ) above −1 z-scores at discharge. Children admitted with lower
MUAC had higher proportional weight gains (p < 0.001) and longer lengths of stay (p < 0.0001). MUAC at
admission and attendance were both independently associated with cure (p < 0.0001). There was no association with
negative outcomes at three months post discharge for children with heights at admission below 65 cm than for taller
children (p = 0.5798).
Conclusions: These results are consistent with MUAC≥ 125 mm for two consecutive visits being a safe and practicable
discharge criterion. Use of a MUAC threshold of 125 mm for discharge achieves reasonable lengths of stay and was
also found to be appropriate for children aged six months or older who are less than 65 cm in height at admission.
Early detection and recruitment of SAM cases using MUAC in the community and compliance with the CMAM
treatment protocols should reduce lengths of stay and associated treatment costs.
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Background
The use of mid-upper arm circumference (MUAC) as a
general tool (i.e. for case-finding, referral, admission,
monitoring response to treatment, and discharge) has
the potential to simplify the practical application of
community-based management of acute malnutrition
(CMAM) services, facilitating their delivery within
the framework of primary and community health
services.
In 2007 the use of MUAC for case-finding, referral,
and admission to CMAM services was accepted by the
World Health Organisation (WHO), the World Food
Program (WFP), the United Nations Standing Commit-
tee on Nutrition (UN/SCN), and the United Nations
Children’s Fund (UNICEF) [1]. MUAC is now widely
used in CMAM programs for these purposes.
The use of proportional weight gain as a discharge cri-
terion for MUAC admissions is no longer recommended
by WHO [2], as it had proven to be problematic with
the most malnourished cases receiving the least amount
of treatment. While the use of MUAC greater than
125 mm has been used in some settings prior to the
WHO updated recommendations and some studies have
proposed MUAC as an alternative discharge criterion to
percentage weight gain [3, 4] for MUAC admissions, the
safety of using MUAC greater than 125 mm as a dis-
charge criterion has not been validated [2].
A consultation between academics and non-governmental
organisations (NGOs) in December 2012 [5] con-
cluded that there were concerns over the safety of
using MUAC as a discharge criterion due to a lack of
evidence with regard to post-discharge relapse and
mortality rates. Also, anecdotal evidence suggested
that children over six months of age with heights less
than 65 cm admitted with low MUAC would experi-
ence very long lengths of stay and may not reach the
MUAC discharge threshold within sixteen weeks
(112 days) of admission. Published evidence was con-
sidered to be inadequate to inform programming.
The aims of this study were to evaluate the safety and
practicability of using MUAC as a discharge criterion for
children aged 6 to 59 months admitted to outpatient
treatment for SAM using MUAC.
Ethics statement
Written consent was obtained from a parent (or primary
caregiver) of the child to be enrolled in the study. Each
parent/caregiver signed an individual consent form de-
tailing the proposed treatment, the right to refuse enrol-
ment into the study, the right to confidentiality and
anonymity and that no payment would be received for
participation.
This study complied with World Medical Association
Declaration of Helsinki (Ethical Principles for Medical
Research Involving Human Subjects, 1964) and was
approved by the National Health Sciences Research
Committee of Malawi (NHSRC, protocol # 817).
Methods
The study design was a standards-based trial. There are
no internationally agreed standards for post-discharge
relapse and mortality in CMAM programs. The standard
adopted for the study was informed by a review by
Ashworth [6, 7], which used a standard of < 10 % relapse
as a ‘criterion for success’ for community-based nutritional
rehabilitation programmes prior to the development of
the CMAM treatment approach. A standard of less than
10 % for combined post discharge relapse and non-
accidental, non-violent death was adopted for the study
through consultation with experts in CMAM program-
ming at FANTA/AED. This standard was more stringent
than the standard used by Ashworth. In this article we
present estimates for post-discharge relapse and mortality
separately and combined so as to allow comparison
against other standards.
The study was conducted in five outpatient health fa-
cilities run by the Government of Malawi Ministry of
Health (MoH) and located in Lilongwe District, Malawi,
with care delivered by MoH staff. A research team from
Valid International (comprised of a research coordinator,
a registered nurse, and a community mobilisation offi-
cer) trained MoH staff in study protocols and assisted
directly in the measurement and treatment of all study
subjects. The Malawi National Guidelines for Community-
based Therapeutic Care [8] formed the standard of care.
At the start of the study the admission criterion for the
treatment of SAM was MUAC< 110 mm according to the
Malawi National guidelines. These guidelines were in the
process of being revised to meet the recommendation of
the UN Joint Statement of 2009 [2] to raise the admission
criteria to MUAC < 115 mm. The clinics in which the
study subjects were recruited changed the admission cri-
teria to MUAC ≤ 115 mm ahead of the publication of the
revised guidelines with the consent of the Ministry of
Health.
The study enrolled children aged between 6 and
59 months with uncomplicated severe acute malnutrition
(SAM) as defined by MUAC ≤ 115 mm and without med-
ical complications. Children with a MUAC ≤ 115 mm with
concurrent bilateral pitting oedema or medical complica-
tions were referred to inpatient care according to Malawi
National Guidelines and enrolled into the study on their
return from inpatient care.
Subjects were recruited between February 2011 and
March 2012. Age was verified by reference to the child’s
‘health passport’. Children whose caregivers were resi-
dent outside of Lilongwe District were excluded from
the study but were admitted to the CMAM program and
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provided with standard care according to the Malawi
National Guidelines. MUAC, weight and height were
measured on admission. An appetite test was conducted
to confirm the appropriate consumption of Ready to Use
Therapeutic Food (RUTF) which is required in order to
receive treatment as an outpatient.
Routine medications given on admission followed the
Malawi National Guidelines and included a broad
spectrum antibiotic (amoxicillin or co-trimoxazole) and
vitamin A. Each child was assessed for malaria using a
rapid diagnostic test, (Paracheck Pf®), and if positive, was
treated with antimalarials (lumefantrine and artemether).
If the Paracheck Pf®, rapid test was unavailable, the
patient was treated empirically for malaria if they pre-
sented with a fever of unknown origin. Each caregiver
and child was routinely offered serial testing for Human
Immunodeficiency Virus (HIV) using the Determine
HIV-1/2 Assay™ and, if tested positive, Uni-Gold Recom-
bigen HIV assay™. HIV positive cases were included in
the study and referred for appropriate treatment. It was
not monitored whether the child went on to receive
treatment for HIV. At each visit the child was given a
ration of RUTF according to their weight (average 180–
200 kcal/kg/day) and at the second visit anthelminthic
treatment (albendazole) was given. The dosage for all
medicines was age or weight related and given according
to the Malawi National Guidelines.
Study subjects were requested to attend outpatient
treatment for SAM on a weekly basis. At each clinic visit
the child was measured for weight and MUAC and their
appetite for RUTF was assessed. Due to the rotation of
MoH clinical staff in attendance at the health centres, a
single observer from the research team conducted each
of the measurements of weight, height, and MUAC in
order to minimise inter-observer variation. The stand-
ardisation of the measurements was assessed using the
method of Habicht [9], using the principle investigator
as the standard, and was reviewed every 3 months.
If the status of the child had not improved or had
deteriorated since the previous visit then the child was
referred to the MoH clinician for further assessment
according to Malawi National Guidelines. Any child
absent from treatment was followed up at home by a
Health Surveillance Assistant (HSA) or community-
based volunteer and encouraged to return for treatment.
Each study subject was discharged ‘cured’ from out-
patient treatment when they achieved a MUAC of
125 mm or greater on two consecutive clinic visits. On
discharge the caregiver was given a fourteen-day supply
of RUTF calculated according to the weight of the child.
The child was referred to a Supplementary Feeding
Program (SFP) if such a program were operating in the
health area of residence. A study subject was also dis-
charged from the study if the child died, ‘defaulted’ (i.e.
was absent for three consecutive visits) or was ‘non-
cured’ (i.e. had not reached the discharge criteria) after
sixteen weeks (112 days). All admissions and discharges
from the study were approved and verified by a member
of the Valid International research team. Any study sub-
ject discharged from the study as ‘non-cured’ was also
assessed according to Malawi National Guidelines and
referred back to the standard Ministry of Health
programme for further treatment if the child had not
reached the discharge criteria as ‘cured’ according to
national guidelines.
Previous studies had indicated that most mortality fol-
lowing treatment for SAM occurs within three months
of discharge [10]. Each child that was discharged as
‘cured’ was followed up every two weeks for a three-
month period by an HSA trained in the study protocols.
At each follow-up visit the child was assessed for illness
(cough, fever, diarrhoea or vomiting) and their MUAC
was measured by the HSA in accordance with their
training in the Integrated Management of Childhood
Illnesses (IMCI) program. Any child who had relapsed
(i.e. met the program admission criteria of MUAC ≤
115 mm or had bilateral pitting oedema) or had deterio-
rated clinically was referred back to the health centre for
assessment and treatment. Relapsed children were eli-
gible for re-admission to the study if their MUAC was
equal to or below 115 mm. Any child absent from their
home for two consecutive home visits was verified as
being lost to follow-up (LTFU) by consulting with mem-
bers of the local community regarding the whereabouts
of the family. The accuracy of the MUAC measurements
and clinical status of the child during follow-up was
assessed by a member of the research team. Verification
visits were made randomly to children in the follow-up
phase of the study and visits were conducted in all cases
where relapse was detected or LTFU had occurred.
No preferential treatment was given to study subjects
compared with non-study subjects.
Data collection and analysis
On admission and at each subsequent visit, the child’s
weight was measured (naked or wearing light undergar-
ments and without shoes) to the nearest 100 g using
Salter™ scales (Salter-Brecknell 235-6S series), the model
used by the health centre for the clinical management of
SAM cases. MUAC was measured to the nearest milli-
metre using a standard non-elastic MUAC tape
(UNICEF supply code S0145620 “MUAC, Child 11.5,
Red/PAC-50”). On admission and discharge the child’s
height was measured to the nearest millimetre using a
standard paediatric height board (supine length was
measured for children less than 24 months of age).
After discharge as ‘cured’, the child was followed up at
home every two weeks for a three-month period by a HSA
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trained in the study protocols. At each follow-up visit the
child was assessed for illness (cough, fever, diarrhoea or
vomiting) and their MUAC was measured by the HSA.
Data were collected on paper forms designed for the
purpose and were entered into an EpiData Version 3.1
(EpiData Association, Odense, Denmark) database using
both interactive checking for range and legal values and
double-entry validation. Statistical analysis was per-
formed using the R Language for Data Analysis and
Graphics [11]. Height-for-age, weight-for-age, and
weight-for-height z-scores were calculated according to
the WHO Child Growth Standard [12]. The Kruskal-
Wallis non-parametric test was used for comparisons of
lengths of stay and proportional weight gain by categor-
ies of MUAC at admission and categories of height at
admission and for comparison of height at admission for
‘cured’ and ‘non-cured’ cases.. The null hypothesis for the
Kruskal-Wallis test is that the data in each group have
the same distribution of the variable of interest. The
strength of association between cure and MUAC at
admission and attendance rate was investigated using
logistic regression.
Results
Table 1 and 2 describes the study cohort at admission.
The study recruited 258 children aged between 6 and
51 months between February 2011 and March 2012 of
whom 115 (44.6 %) were male and 143 (55.4 %) were
female. The study protocol included children aged up to
59 months but none were older than 51 months. Of the
children enrolled in the study, 125 (48.4 %) did not
present with any concurrent illnesses (defined as diar-
rhoea, vomiting, fever, or acute respiratory symptoms)
while 27 (10.5 %) presented with complications severe
enough to require transfer to inpatient care prior to en-
rolment in the study. The remaining 106 (41.1 %) of
children had concurrent illnesses as outlined in Table 1
and 2. 140 (54.3 %) of children were tested for HIV on
admission and of those children, 19 (13.6 %) of 140
(54.3 %) children were tested for HIV on admission
tested positive for HIV.
Figure 1 summarises the anthropometric data of the
study subjects at admission in a Venn diagram [13] in
terms of MUAC, weight-for-height z-score (WHZ),
height-for-age z-score (HAZ) and weight-for-age z-score
(WAZ) according to the World Health Organization
Growth Standards [12]. Only 4 (1.6 %) of the recruited
subjects did not have a WHZ < −2, HAZ < −2, or WAZ
< −2 on admission. The majority (52.9 %) of the study
cohort was undernourished by all three indicators and
by MUAC. A large majority (c. 90 %) of study subjects
were stunted.
Table 3 describes the treatment given to the study sub-
jects. A high proportion of subjects (93.0 %) received
antibiotics while 65.0 % received the full national proto-
col of medicines.
Figure 2 describes the treatment outcomes achieved in
the study and the subsequent exclusions from follow-up.
63.2 % of enrolled subjects were cured while 14.0 %
defaulted, 3.9 % died during treatment and 19.0 % were
discharged as ‘non-cured’. The cure rate for the study
did not meet the Sphere Minimum Standard of 75 %
[14], however, defaulter rates did meet Sphere minimum
standards (i.e. less than 15 %) and the mortality rate was
lower than and met the criteria for success set by WHO
for community based programmes in non-emergency
contexts (i.e. < 5 %) [7, 15]. The low cure rate observed
was primarily due to children being discharged from the
study after 4 months of treatment without attaining the
study discharge criteria. Of the 49 cases discharged as
‘non-cured’ from this study 43 (87.8 %) were discharged
as ‘cured’ according to the existing national guidelines
(MUAC > 115 mm and 2 months minimum stay) while 6
(12.2 %) required continuing care.
The median attendance rate for ‘cured’ patients (as a
percentage of the total number of weekly visits required
of all subjects by the study protocol during treatment)
was 87.0 %. Figure 3a shows a box plot for the attend-
ance rate for ‘cured’ and ‘non-cured’ children and Fig. 3b
shows a box plot for the MUAC-at-admission for ‘cured’
and ‘non-cured’ children. Attendance and MUAC-at-
Table 1 Main characteristics of study subjects at admission
(n = 258a)
Characteristic Number Proportion
Males 115 44.6 %
Females 143 55.4 %
Number with MUAC ≤115 mmb only 248 96.1 %
Number with MUAC ≤ 115 mm and oedema 10 3.9 %
Requiring inpatient carec 27 10.5 %
No concurrent illnesses recordedd 125 48.4 %
Diarrhoead 56 21.7 %
Vomitingd 23 8.9 %
Feverd 65 25.2 %
Respiratory illnessd 73 28.3 %
HIV positivee,f 19 7.4 %
HIV negative 121 46.9 %
HIV status not known (i.e. testing refused) 118 45.7 %
aThere were no refusals
bMUAC tapes were marked in divisions of 1 mm and color-coded. A’red MUAC’,
signifying severe acute malnutrition, was marked red at the 115 mm cut
off point
cInpatient stabilisation care prior to enrolment in the study as per CMAM
National Guidelines
dDoes not sum to 100 % due to some subjects having multiple illnesses
at presentation
eSerial HIV testing according to national protocol using Determine™ and
Uni-Gold Recombigen™ HIV assays
fPrevalence of HIV in those tested was 13.6 %
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admission variables were both independently associated
with cure (p < 0.0001). Each millimetre increase in ad-
mission MUAC resulted in a 2.2 % (95 % CI = 1.47 %;
2.85 %) increase in the odds of cure. Each percentage
point increase in the attendance rate was associated with
a 1.13 % (95 % CI = 0.89 %; 1.38 %) increase in the odds
of cure. These increases appear small but they are for
small increases in variables with wide ranges. A ten
millimetre increase in admission MUAC (e.g. from
102 mm to 112 mm) was associated with a 23.8 % (95 %
CI = 15.7 %; 32.4 %) increase in the odds of cure. A
twenty-percentage point increase in attendance (e.g.
from 60 % to 80 %) was associated with a 25.2 % (95 %
CI = 19.4 %; 31.5 %) increase in the odds of cure.
The 19 children identified as being HIV positive
showed similar treatment outcomes to other children:
‘Cured’ 52.6 %, ‘Died’ 5.3 %, ‘Default’ 21.1 %, and ‘Non-
cured’ 15.8 %.
Figure 4a shows the distribution of duration of treat-
ment episode while Fig. 4b presents box plots describing
the length of stay for three classes of MUAC at admis-
sion. Figure 4c shows the distribution of proportional
weight gains. Figure 4d presents box plots describing
proportional weight gain for three classes of MUAC at
admission. The median length of stay of all children in
the study was 49 days (IQR = 35 days—77 days). Chil-
dren identified as HIV positive and discharged ‘cured’
had a median duration of treatment of 84 days (IQR =
63–105 days). Children with lower MUAC at admission
required longer durations of treatment (Kruskal-Wallis
test, p < 0.0001) with a median duration of treatment in
the lowest MUAC group of 98 days (IQR = 60 days –
105 days) and in the highest MUAC group of 42 days
(IQR = 35 days—63 days).
The median proportional weight gain of all children in
the study was 21 % (IQR = 16 % − 27 %). Children with
lower MUACs experienced higher proportional weight
gains (Kruskal-Wallis test, p < 0.0001) with median pro-
portional weight gain of 42 % in the lowest MUAC
group (IQR = 40 % − 47 %) and 18 % in the highest
MUAC group (IQR = 14 % − 22 %).
Figures 5a and b present box plots describing the
length of stay and proportional weight gain by height at
admission for two height classes at admission respect-
ively. Children recruited to the study with a height at ad-
mission below 65 cm showed a higher proportional
weight gain (Kruskal-Wallis test, p = 0.0003) and a lon-
ger median length of stay under treatment than taller
children (Kruskal-Wallis test, p = 0.0145). These chil-
dren were no more likely to be discharged as ‘non-
Table 2 Main characteristics of study subjects at admission (n = 258a)
Characteristic Minimum Lower Quartile Median Mean Upper Quartile Maximum
Age at admission (months) 6.0 10.0 14.0 16.4 21.0 51.0
MUAC at admission (cm)c 8.0 10.4 11.0 10.8 11.4 11.5
Height at admission (cm) 53.3 62.5 67.4 67.6 72.2 92.5
Median duration of inpatient episode (days)b 2.0 5.0 7.0 8.3 9.0 25.0
aThere were no refusals
bInpatient stabilisation care prior to enrolment in the study as per CMAM National Guidelines
c101 (39.1 %) of admissions were below 65 cm in height
Fig. 1 Venn diagram showing anthropometric categories of
all admissions
Table 3 Treatment given in programme
Treatment Number Percentage
RUTFa 258 100.0 %
Vitamin A 203 78.7 %
Antimicrobials 238 92.2 %
Anthelminthicsb 108 67.1 %
Antimalarials 82 31.8 %
Received full CMAM protocolc 168 65.1 %
Referred for inpatient cared 35 13.6 %
aQuantity given according to national protocol (average 180–200 kcal/kg/day)
bGiven to eligible children ≥ 12 months only (according to national protocol).
79.1 % of all cases received the correct age appropriate intervention
cAs per CMAM National Guidelines
dChildren referred to inpatient care as per CMAM National Guidelines
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cured’ than taller children (relative risk (RR) = 0.93,
95 % CI = 0.77 − 1.13, chi-square = 0.33, p = 0.5667).
There was no association with negative outcomes at
three months post discharge for children with heights
at admission below 65 cm than for taller children
(RR = 1.22, 95 % CI = 0.21–7.09, Fisher’s exact test
(single-tailed with HA := RR > 1), p = 0.5798).
The median height at admission of ‘cured’ cases was
67.5 cm (IQR = 63.5–72.6) and the median height at
admission of ‘non-cured’ cases was 66.5 cm (IQR =
60.8–70.1). Lower height at admission was not signifi-
cantly associated with being’non-cured’ (Kruskal Wallis
test, p = 0.0645).
The median height at admission for those known to
have died was 62.2 cm (IQR = 60.1–65.9) and the me-
dian height at admission for those not known to have
died was 67.5 cm (IQR = 63.0–72.3). Lower height at
admission was significantly associated with mortality
(Kruskal Wallis test, p = 0.0369). This analysis should be
interpreted with caution as defaulter follow-up was
Fig. 2 Flow diagram showing outcomes and exclusions. The study was discontinued at two health centres due to a fall to zero recruitment
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limited and deaths in defaulters may have not been de-
tected and recorded.
Eight children were excluded from the follow-up por-
tion of the analysis. Follow-up was discontinued in these
cases due to closure of the study site, relocation of the
subject to another district, and inability to be followed
because the family were from outside of the health dis-
trict and had provided an incorrect address upon regis-
tration in order to qualify to receive care.
The proportion of patients discharged as ‘cured’ and
experiencing relapse to SAM (1.9 %, 95 % CI = 0.4 %–
5.6 %) or non-violent/non-accidental death (1.3 %, 95 %
CI = 0.2 %–4.6 %) was 3.2 % (95 % CI = 1.1 %–7.4 %, p =
0.0013, binomial test with the alternative hypothesis that
the proportion of failures is below 10 %). None of the
children identified as HIV positive and discharged
‘cured’ either ‘relapsed’ or ‘died’ within the three-month
follow-up period.
Of the 155 children followed up after being discharged
as ‘cured’, 29 % (n = 45) receivedSFP rations. There were
no negative outcomes amongst these 45 children after
three months of follow-up (Risk difference = 4.55 %,
95 % CI = 0.65 %–8.44 %, Fisher one-tailed p-value =
0.1752). Of the 45 children receiving SFP, 20 % (n = 9)
became moderately acutely malnourished (MAM) with a
MUAC between 11.5 and 12.4 cm during the follow-up
period. 44 % (n = 4) of those who became MAM during
follow-up remained MAM at the last follow-up visit.
The study data for the children who ‘died’ or ‘relapsed’
are shown in Table 4. A detailed follow-up investigation
of the deaths indicated that in both cases the child had
accessed medical services at a hospital prior to death.
Regarding relapses, one child was absent for 4 out of
the 6 follow-up visits prior to relapse but did not have
any illnesses recorded; the second child was recorded to
have had diarrhoea, fever and cough in the week prior to
relapse and the third child had a cough recorded for
weeks 2 and 3 but no other illnesses recorded during the
week prior to the relapse being detected in week 5.
Limitations
There are several limitations to this study. Occasional
interruptions in the MoH supply of routine medicines
lead to shortages of some medicines. When this oc-
curred the MoH clinician decided on the appropriate
use of resources; no priority was given to study subjects.
The National Health Sciences Research Committee of
Malawi was consulted and ethical approval was given to
continue the study despite not all of the study subjects
receiving the full CMAM protocol of treatment. The
results thus reflect the outcomes achieved in a MoH
treatment setting with limited resources.
Following discharge from the study cohort as ‘non-
cured’ according to the study criteria, children were
assessed for the need for continued treatment or dis-
charged according to the Malawi National guidelines.
The compliance and outcome of children who were dis-
charged from the study cohort but who continued treat-
ment or were discharged as ‘cured’ were not followed up
as part of this study.
The limited follow-up of absentees and defaulters dur-
ing the course of treatment contributed to a reduction
in the proportion of the children who were recruited to
Fig. 3 a Box plot describing Attendance rate for ‘cured’ and ‘non-cured’ SAM cases. b: Box plot describing MUAC at admission for ‘cured’ and
‘non-cured’ SAM cases
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the study and later discharged as ‘cured’, thus limiting
the sample size of the study.
The study did not follow compliance with referral for
antiretroviral prophylaxis or treatment for HIV for HIV
positive cases, however only small differences were ob-
served in programmatic outcomes between HIV positive
and HIV negative subjects. The small number of HIV
positive subjects did not allow disaggregation of the dur-
ation of treatment by MUAC on admission. This issue
might be investigated in a larger cohort of HIV positive
subjects receiving nutritional rehabilitation prior to
starting antiretroviral therapy.
The analyses carried out with this study design were
not able to demonstrate that alternative discharge cri-
teria would have resulted in fewer negative outcomes
than a discharge criterion of MUAC ≥ 125 mm.
Discussion
The study confirms that a discharge criterion of MUAC
greater than 125 mm for two consecutive visits repre-
sents a practicable and safe discharge criterion according
to the standard established for the study and is also an
appropriate discharge criterion for children with a height
of less than 65 cm at admission. Relapses formed 1.9 %
Fig. 4 a Histogram showing distribution of duration of treatment episode. b: Box plots describing the length of stay for three classes of MUAC at
admission c Histogram showing the distribution of proportional weight gains at discharge. d Box plots describing proportional weight gain at
discharge for three classes of MUAC at admission
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(95 % CI = 0.4 %–5.6 %) of the cohort of ‘cured’ patients
and non-accidental and non-violent deaths formed 1.3 %
(95 % CI = 0.2 %–4.6 %) of the cohort of ‘cured’ patients
over the three-month follow-up period. Negative out-
comes occurred in 3.2 % (95 % CI = 1.1 %–7.4 %) of the
cohort of ‘cured’ patients over the three-month follow-
up period. None of the negative outcomes observed dur-
ing the 3-month follow-up were in children identified as
HIV positive at admission. Post-discharge deaths were
not associated with relapse to SAM and were not associ-
ated with having a discharge WHZ below −2 z-scores.
While there are no internationally agreed standards for
relapse and mortality following cure from CMAM pro-
grammes, all cases with a negative outcome following
discharge had a discharge WHZ above −1 z-scores. This
suggests that MUAC ≥ 125 mm for two consecutive visits
is as at least safe as discharge using WHZ > − 1 z-scores.
The rate of relapse and mortality following discharge as
‘cured’ reported in this study are also similar or lower to
those reported by Ashworth in other studies using weight
for height (e.g. WHZ> −1 or weight-for-height percentage
of median > 85 %) as the discharge criterion from CMAM
programmes [7].
Children with lower MUAC at admission had longer
durations of treatment and higher proportional weight
gains than the children admitted with a higher MUAC.
This shows that the MUAC discharge criterion ensures
children who are the most malnourished remain under
treatment longer and are discharged with a higher propor-
tional weight gain. This eliminates the problems previously
identified with the proportional weight gain criterion [4]
and its association with under-treatment for the most
Fig. 5 a Box plot describing length of stay by height at admission for two height classes. b: Box plot describing proportional weight gain by
height at admission for two height classes
Table 4 Details of study subjects with negative outcomes in the three months following their discharge with a MUAC of 125 mm
or greater (n = 5)
Admission Discharge Follow-up
Outcome Sex Age (months) MUAC (mm)a MUAC (mm) WHZ Length of
stay (days)
Weight
gain (%)
Duration of
follow-upb (weeks)
Last known
MUAC (mm)c
Illness during
follow-up
Death F 9 112 125 +0.30 56 10.0 10 134 diarrhoea cough
Death F 14 110 128 −0.01 105 14.7 6 120 diarrhoea vomiting
fever cough
Relapse M 14 110 126 −0.08 84 26.8 12 110 none recorded
Relapse M 12 104 130 −0.39 35 26.8 8 114 diarrhoea vomiting
fever cough
Relapse F 9 110 128 −0.65 112 30.0 6 115 diarrhoea
aNone of the children followed-up had oedema at admission
bThe follow-up visit prior to death or the follow-up visit when relapse was detected
cLast known MUAC for deaths is the MUAC recorded in the follow-up visit prior to death. Last known MUAC for relapsed cases is the MUAC at the follow-up visit
at which relapse was detected. Relapsed cases were referred back to the therapeutic feeding program
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malnourished individuals. Children identified as HIV posi-
tive at admission had a longer median duration of treat-
ment than that observed for all children combined.
Children with height less than 65 cm at admission also
showed greater proportional weight gain and had longer
lengths of stay than taller children and showed no asso-
ciation with negative outcomes three months after dis-
charge. These findings may be partly explained due to
younger children typically having higher weight gains
even when well nourished and that, on average, younger
children are shorter. However, these children respond
and benefit the most from treatment, and the evidence
of this study should allay concerns that using MUAC is
not appropriate as an admission or discharge criterion
for stunted children aged 6 months or older with a
height below 65 cm.
A high proportion of children (92.2 %) received anti-
microbials during treatment although the compliance
with protocol was lower for Vitamin A and anthel-
minthics. A low proportion of children (65.1 %) received
the full CMAM protocol of medicines. This was due to
shortages of supply at the clinics. Whilst this may repre-
sent a limitation to this study, the outcomes of the study
reflect the context of an MoH programme with supply
shortages.
Reasons for defaulting included waiting times for treat-
ment at the clinic site and prioritisation of household
labour (e.g. harvesting). Some defaulters had reportedly
migrated away from their temporary home in the treat-
ment catchment area.
It was expected that enrolment into SFP after cure
would have a large positive effect on negative outcomes
following discharge, however, negative outcomes were
rare and any analysis will lack statistical power to detect
all but very large effects. The data suggest a small posi-
tive effect of SFP enrolment may be present.
Study findings included a high non-cure rate (18.9 %)
for all children combined (15.8 % for children identified
as HIV positive at admission). MUAC at admission and
attendance rate were positively associated with cure.
In the absence of the incentivised follow-up of absen-
tees and defaulters; reducing waiting and transit times
for clinic visits, frequent counselling to refrain from
sharing RUTF, and case review by physicians did little to
improve attendance and reduce the non-cure rate over
time.
These results provide strong evidence that the propor-
tion ‘cured’ can be influenced by program design and ac-
tivities that improve the detection, early recruitment and
retention of SAM cases as well as compliance to the
SAM treatment protocol.
Care should be taken in extrapolating these results
to other populations, however data from CMAM pro-
grammes using the same discharge criterion in other
contexts report similar findings in terms of median
duration of treatment (approximately 8 weeks or
56 days). [3, 4].
Additional studies may be needed to assess whether a
discharge criterion of MUAC ≥ 125 mm is safe in other
CMAM programs with low levels of supervision and in
other settings. There are currently no internationally
agreed standards by which to assess the safety of MUAC
or other discharge criteria, however this study indicates
that low rates of relapse and mortality following cure are
achievable in low resource, non-emergency settings.
Conclusions
This study confirms that a discharge criterion of
MUAC ≥ 125 mm is safe and practical leading to low
mortality and relapse at three months post discharge in
the context of Malawian Ministry of Health outpatient
care facilities. Negative outcomes were not associated
with failing to meet the WHZ > −2 z-scores criterion.
This MUAC discharge criterion was also found to be ap-
propriate for children aged six months or older who are
less than 65 cm in height at admission. Compliance, as
measured by attendance rate, and MUAC at admission
were both positively associated with cure.
Children admitted with lower MUAC remain under
treatment longer and achieve higher proportional weight
gains when MUAC discharge criteria are used. The
introduction of MUAC discharge may lead to longer
average length of stay initially where there is limited case
finding and admission MUAC may be expected to be
low. Early detection and recruitment of severe acute
malnutrition cases using MUAC in the community and
compliance with the CMAM treatment protocols
should, however, reduce lengths of stay and associated
treatment costs.
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